Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients

NCT04075513 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

343

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Insulin glargine, 300 U/ml
DRUG: Insulin degludec, 100U/ml
DRUG: Background therapy: Rapid acting insulin analogs

Sponsor

Sanofi